Indeed, we found that pharmacological inhibition of IGF2/IGF1R signaling with linsitinib decreased AKT phosphorylation and attenuated bladder cancer cells’ SOX2-mediated colony-forming ability. The gene discussed is IGF2; the disease is urinary bladder cancer.